Baillie Gifford is an independently owned firm that focuses on investment and asset management.
Business Model:
Revenue: $1B
Employees: 1,001-5,000
Address: Calton Square, 1 Greenside Row
City: Edinburgh
State: scotland
Zip: EH1 3AN
Country: GB
Baillie Gifford is an independently owned investment management firm. It is owned and run by 39 of its senior executives who operate as a partnership, a structure which has endured for over a century and which provides stability for clients and motivation for employees. It enables them to manage the business for the future as well as the present, with the emphasis on genuine long–term thinking rather than lurching haplessly between short term targets. Baillie Gifford is unique in the UK in being a large-scale investment business that has remained an independent private partnership. This ownership structure has allowed them to keep their efforts focused entirely on their clients and their investments.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
9/2021 | Solugen | Series C | 0 |
12/2020 | Graphcore | Series E | 0 |
5/2021 | Workrise | Series E | 0 |
1/2022 | DNA Script | Series C | 0 |
2/2020 | Graphcore | Series D | 150M |
10/2020 | Tanium | Private Equity Round | 150M |
10/2018 | Tanium | Private Equity Round | 200M |
4/2021 | Astranis | Series C | 250M |
12/2018 | SpaceX | Series J | 486.2M |
8/2020 | Warby Parker | Series G | 120M |
4/2021 | Capsule | Series D | 300M |
11/2015 | CureVac | Series F | 0 |
5/2021 | MasterClass | Series F | 0 |
9/2020 | Northvolt | Series B | 0 |
10/2021 | Honor | Series E | 70M |
3/2021 | ChargePoint | Post-IPO Equity | 225M |
1/2016 | Flatiron Health | Series C | 175M |
4/2022 | Lightning Labs | Series B | 0 |
9/2021 | Discord | Series H | 500M |
8/2021 | Databricks | Series H | 0 |
7/2020 | Wise | Secondary Market | 319M |
1/2022 | Wayve | Series B | 0 |
9/2018 | KSQ Therapeutics | Series C | 80M |
11/2017 | Bolt Threads | Series D | 123M |
1/2017 | Funding Circle | Series F | 100M |
11/2017 | Uptake Technologies | Series D | 117M |
6/2021 | FlixBus | Series G | 0 |
1/2021 | Horizon Robotics | Series C | 0 |
12/2022 | BillionToOne | Series C | 0 |
8/2021 | Databricks | Series H | 1.6B |
6/2021 | Northvolt | Venture Round | 0 |
7/2021 | Redwood Materials | Series C | 700M |
9/2020 | Zymergen | Series D | 300M |
11/2021 | Grammarly | Private Equity Round | 200M |
9/2021 | Snyk | Series F | 304M |
8/2018 | Slack | Series H | 427M |
4/2018 | Manbang Group | Private Equity Round | 0 |
11/2021 | Aker Horizons | Post-IPO Equity | 116.6M |
3/2022 | Blockchain.com | Series D | - |
4/2015 | Funding Circle | Series E | 150M |
8/2021 | Joby Aviation | Post-IPO Equity | 0 |
9/2020 | Gojo &a; Company | Series D | 0 |
6/2022 | Echodyne | Series D | 0 |
11/2021 | Faire | Series G | 0 |
11/2021 | Aurora | Post-IPO Equity | 0 |
10/2016 | UNITY Biotechnology | Series B | 116M |
3/2018 | UNITY Biotechnology | Series C | 55M |
8/2017 | UNITY Biotechnology | Series B | 35M |
8/2020 | Epic Games | Equity | 1.5B |
11/2020 | Manbang Group | Private Equity Round | 1.7B |
10/2019 | Workrise | Series D | 0 |
12/2021 | Pet Circle | Series C | 0 |
9/2016 | Intarcia Therapeutics | Series E | 0 |
3/2016 | Home24 | Venture Round | 22.8M |
7/2021 | Rappi | Series F | 500M |
11/2019 | Convoy | Series D | 400M |
11/2017 | HeartFlow | Series E | 0 |
5/2021 | Delhivery | Series H | 277M |
1/2021 | Lyra Health | Series E | 187M |
10/2020 | Honor | Series D | 140M |
8/2021 | Blockstream | Series B | 210M |
6/2020 | Lilium | Venture Round | 35M |
4/2023 | HeartFlow | Series F | 0 |
6/2022 | Echodyne | Series C | 0 |
6/2019 | Carbon | Series E | 0 |
4/2021 | Epic Games | Equity | 1B |
7/2022 | Merlin Labs | Series B | 0 |
5/2019 | Tempus | Series F | 0 |
8/2018 | Tempus | Series E | 110M |
6/2021 | SHINE Medical Technologies | Series C | 150M |
11/2020 | Nuro | Series C | 500M |
9/2020 | Allbirds | Series E | 0 |
1/2020 | Allbirds | Series D | 25M |
7/2019 | FlixBus | Series F | 563.1M |
11/2017 | Wise | Series E | 280M |
9/2020 | Affirm | Series G | 500M |
12/2020 | Tempus | Series G | 200M |
10/2022 | Recursion Pharmaceuticals | Post-IPO Equity | 150M |
11/2021 | Nuro | Series D | 0 |
8/2021 | VerSe Innovation | Series I | 451M |
6/2021 | sennder | Series D | 80M |
3/2017 | Moneytree | Series B | 9M |
1/2016 | Meituan | Venture Round | 3.3B |
7/2019 | Thumbtack | Series F | 150M |
12/2016 | HelloFresh | Series G | 88.3M |
8/2015 | Zocdoc | Series D | 130M |
5/2021 | sennder | Series D | - |
1/2022 | McMakler | Venture Round | 0 |
3/2019 | Zipline | Series D | 120M |
12/2017 | Carbon | Series D | 0 |
5/2017 | AUTO1 Group | Series E | 402.4M |
4/2020 | Warby Parker | Series F | 125M |
4/2022 | Convoy | Series E | 0 |
4/2022 | Indiabulls Real Estate | Post-IPO Equity | 0 |
11/2015 | Ola | Series F | 500M |
4/2022 | UPSIDE Foods | Series C | 0 |
3/2021 | Loft | Series D | 0 |
12/2014 | Momentive | Private Equity Round | 250M |
12/2020 | Zomato | Series J | 660M |
2/2016 | Souq | Venture Round | 275M |
11/2017 | NIO | Series D | 1.1B |
10/2021 | Brex | Series D | 300M |
6/2020 | Oscar Health | Private Equity Round | 225M |
3/2021 | Stripe | Series H | 600M |
3/2020 | Tempus | Series G | 0 |
9/2015 | Thumbtack | Series E | 125M |
9/2021 | Spiber Inc. | Private Equity Round | 0 |
6/2021 | Thumbtack | Series I | 275M |
4/2022 | VerSe Innovation | Series J | 0 |
3/2021 | Gopuff | Series G | 0 |
12/2020 | Oscar Health | Pre-IPO | 140M |
12/2014 | Flipkart | Series H | 700M |
12/2017 | Lyft | Series H | 0 |
3/2022 | PropertyGuru | Post-IPO Equity | 0 |
3/2022 | BillionToOne | Series C | 0 |
1/2020 | Joby Aviation | Series C | 0 |
3/2023 | Stripe | Series I | 6.5B |
10/2019 | Scopely | Series D | 400M |
9/2020 | Recursion Pharmaceuticals | Series D | 239M |
10/2022 | Solugen | Series D | 0 |
4/2022 | Climeworks | Private Equity Round | 0 |
9/2015 | HelloFresh | Series F | 85.6M |
6/2021 | Relativity Space | Series E | 0 |
4/2020 | Cohesity | Series E | 250M |
12/2017 | Orchard Therapeutics | Series B | 0 |
6/2016 | Ginkgo Bioworks | Series C | 0 |
5/2018 | Akili Interactive Labs | Series C | 0 |
5/2021 | Akili Interactive Labs | Series D | 0 |
4/2020 | PsiQuantum | Series C | 150M |
8/2018 | Orchard Therapeutics | Series C | 0 |
6/2020 | Sana Biotechnology | Series A | 700M |
11/2015 | Udacity | Series D | 105M |
3/2021 | Blockchain | Series C | 0 |
8/2016 | Denali Therapeutics | Series B | 130M |
4/2020 | Zomato | Series J | 5M |
10/2018 | NIO | Post-IPO Equity | - |
5/2016 | Wise | Series D | 26M |
5/2019 | Wise | Secondary Market | 292M |
3/2018 | Zipline | Series C | 70M |
7/2022 | Northvolt | Convertible Note | 0 |
5/2019 | Away | Series D | 100M |
6/2021 | Zipline | Series E | 250M |
1/2016 | Skyscanner | Venture Round | 192M |
6/2015 | Home24 | Venture Round | 131.1M |
9/2020 | Jiangxiaobai | Venture Round | 300M |
9/2018 | Indigo | Series E | 250M |
7/2021 | PsiQuantum | Series D | 450M |
9/2017 | Indigo | Series D | 203M |
7/2022 | Merlin Labs | Series B | 0 |
7/2022 | Northvolt | Convertible Note | 0 |
6/2022 | Echodyne | Series D | 0 |
4/2022 | Convoy | Series E | 0 |
4/2022 | UPSIDE Foods | Series C | 0 |
4/2022 | Indiabulls Real Estate | Post-IPO Equity | 0 |
4/2022 | VerSe Innovation | Series J | 0 |
4/2022 | Climeworks | Private Equity Round | 0 |
4/2022 | Lightning Labs | Series B | 0 |
3/2022 | BillionToOne | Series C | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|